의료 분야 가상현실(VR) 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the virtual reality in Healthcare market size is expected to grow from USD 5.15 billion in 2025 to USD 6.51 billion in 2026 and is forecast to reach USD 20.99 billion by 2031 at 26.39% CAGR over 2026-2031.

This report Segments the Industry Into Component (Hardware, Software, Services), Application (Pain Management, Education and Training, Surgery, Patient Care Management, Rehabilitation and Therapy Procedures, Other Applications), End Use (Hospitals and Clinics, Research Organizations and Pharma Companies, Other End Uses), and Geography (North America, Europe, Asia-Pacific, and More).

Global Virtual Reality In Healthcare Market Trends and Insights

Rising Adoption of VR for Surgical Training & Simulation

Surgical education is shifting from observation to experiential skill building. Randomized trials in 2024 confirmed that virtual procedures improved accuracy and shortened learning curves at leading U.S. teaching hospitals. Several surgical teams successfully deployed Apple Vision Pro headsets during live cases, proving intraoperative viability and sparking demand for device-agnostic, sterile-field-ready apps. Platform vendors now bundle haptic controllers and AI-guided assessment dashboards that score performance and feed data into credentialing systems. Pharmaceutical firms are joining the ecosystem by commissioning custom extended-reality modules that teach drug administration protocols alongside operative steps. Hospital networks that form "spatial computing centers of excellence" report faster staff onboarding and lower per-resident training costs, underscoring a business case that is forcing laggard institutions to reassess investment priorities.

Growing Demand for Pain Management & Mental-Health Therapies

A sharp policy pivot toward non-pharmacological pain relief, driven by the opioid crisis, has lifted virtual analgesia into mainstream care. FDA-authorized systems such as RelieVRx demonstrated durable pain reduction in almost 70% of patients 18 months after therapy, prompting the Centers for Medicare & Medicaid Services to activate three HCPCS codes that reimburse digital mental-health devices from January 2025. Academic medical centers now pair VR mindfulness modules with biofeedback sensors, and early real-world evidence indicates improved adherence compared with mobile-app counterparts. AI-powered therapy companions analyze gaze, voice, and physiologic data to adjust scene intensity in real time, broadening access for diverse socioeconomic groups and minimizing clinician workload.

High Upfront Hardware & Integration Costs

Smaller providers struggle to fund capital purchases, staff training, and EHR integration simultaneously. Although baseline headset prices are falling, medical-grade add-ons such as sterilizable face cushions, 3D tracking cameras, and FDA-cleared haptic controllers keep bills elevated. Software licensing typically follows annual per-seat models that can rival the hardware cost within three years. Many administrators still lack clear return-on-investment templates, especially for non-reimbursed use cases like staff wellness or patient distraction during phlebotomy. Grants and pilot subsidies help, but sustained scaling often hinges on value-based contracts that share savings from reduced readmissions or opioid prescriptions.

Other drivers and restraints analyzed in the detailed report include:

1. Technology Cost Reductions and Improved Hardware
2. Expansion of Telemedicine Integrating VR
3. Data-Privacy & Cybersecurity Concerns

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Hardware accounted for 61.58% of 2025 revenue, underscoring its foundational role in the Virtual Reality in Healthcare market. Global headset shipments to hospitals rose sharply after vendors optimized optical stacks for prolonged clinical wear and rolled out plug-and-play sterilization kits. Gesture tracking and force-feedback peripherals are spreading from orthopedics into cardiology and endoscopy training programs. The Virtual Reality in Healthcare market size for software, while smaller today, is compounding at 28.48% annually as hospitals pivot to content subscriptions, AI-driven progress dashboards, and cloud-rendered multi-user scenarios. Regulatory-grade software development kits now ship with pre-filled documentation templates that speed FDA submissions, shortening time-to-revenue for independent developers.

Service revenues lag the two core segments yet remain vital. Health systems increasingly outsource design of VR skills-labs, endpoint provisioning, and cross-platform content curation. Consultants bundle change-management workshops that teach clinicians how to embed VR protocols in existing care pathways, strengthening long-term customer lock-in and boosting recurring revenues as software refresh cycles accelerate.

Surgery simulation retained 32.10% share in 2025, with deployments in orthopedics, neurosurgery, and minimally invasive specialties continuing to expand. The Department of Veterans Affairs highlighted strong evidence for VR rehearsal boosting procedural confidence in novice surgeons. Meanwhile, rehabilitation and physical therapy captured payer attention after studies showed 20% faster gait-speed recovery for stroke survivors who engaged in immersive balance tasks. The Virtual Reality in Healthcare market size tied to rehabilitation is therefore scaling swiftly in absolute dollars despite its smaller base. FDA-authorized pain treatment modules further blur boundaries between rehab and chronic-pain care.

Medical education apps are diversifying into nursing, pharmacy, and emergency medicine, signaling broader curricular adoption. Patient-care-management tools, including exposure therapy and perioperative anxiety reduction modules, are winning grants aimed at lowering sedative use. Application developers who combine evidence generation with robust analytics dashboards gain an edge, because hospitals must demonstrate measurable functional gains to secure ongoing reimbursement.

Complete Report Scope:

• By Component (Value, USD bn)
  • Hardware
    • Devices
      • Head-Mounted Displays
      • Gesture-Tracking Devices
      • Projectors & Display Walls
      • Other Devices
    • Accessories
  • Software
  • Services
• By Application (Value, USD bn)
  • Surgery Simulation & Training
  • Pain Management & PTSD
  • Rehabilitation & Physical Therapy
  • Medical Education & Training
  • Patient Care Management
  • Other Applications
• By End-User (Value, USD bn)
  • Hospitals & Clinics
  • Academic & Research Institutes
  • Rehabilitation Centers
  • Diagnostic Centers
  • Other End-Users
• By Delivery Mode (Value, USD bn)
  • Immersive VR
  • Semi-Immersive VR
  • Non-Immersive VR
• By Geography (Value, USD bn)
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa

Geography Analysis

North America controlled 42.85% of 2025 revenue, supported by a proactive FDA that issued a dedicated 21 CFR code for VR behavioral-therapy devices and a Transitional Coverage for Emerging Technologies rule that accelerates Medicare payments. Large integrated-delivery networks budget for immersive technology labs and continually feed outcome data to payers, reinforcing virtuous adoption cycles. Insurers in the region now review VR claims under durable-medical-equipment criteria, giving providers a clearer cost-recovery path.

Europe follows with steady uptake driven by public-sector pilots and cross-border research consortia. Compliance with the EU's General Data Protection Regulation shapes system design, fostering robust security architectures that are becoming global blueprints. Germany's hospital-funding reforms in 2025 earmarked capital for digital therapeutics, and France's national health authority published clinical-practice guidelines that recommend VR analgesia for certain chronic-pain cohorts.

Asia-Pacific is the fastest-growing region, posting a 30.05% CAGR. Local electronics supply chains trim headset bills, while government grants encourage rural tele-rehabilitation. Japan's aging population fuels demand for fall-prevention programs, and Australia's national insurance scheme has begun reimbursing VR chronic-pain modules for eligible patients. The Virtual Reality in Healthcare market size across APAC is therefore projected to surpass European totals earlier than once anticipated.

South America and the Middle East & Africa are smaller today but gaining momentum. Brazilian private hospitals deploy VR for pediatric oncology distraction, and Gulf states include immersive simulation centers in new medical-city master plans. Partnerships with global OEMs and university research hubs are accelerating technology transfer, bypassing legacy barriers that once slowed digital-health adoption.

1. Microsoft
2. Meta Platforms, Inc.
3. HTC
4. Sony Group
5. Siemens Healthineers
6. GE HealthCare Technologies Inc.
7. Osso VR, Inc.
8. Surgical Theater, Inc.
9. MindMaze SA
10. XRHealth USA, Inc.
11. AppliedVR, Inc.
12. Medical Realities Ltd.
13. SyncThink, Inc.
14. Vicarious Surgical, Inc.
15. ImmersiveTouch, Inc.
16. Samsung Group
17. VirtaMed
18. CAE
19. FundamentalVR Ltd.
20. BehaVR, LLC

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising adoption of VR for surgical training & simulation
  • 4.2.2 Growing demand for pain management & mental-health therapies
  • 4.2.3 Technology cost reductions and improved hardware
  • 4.2.4 Expansion of telemedicine integrating VR
  • 4.2.5 Government reimbursement pilots for VR digital therapeutics
  • 4.2.6 Spatial-AI analytics enabling outcome-based rehabilitation
• 4.3 Market Restraints
  • 4.3.1 High upfront hardware & integration costs
  • 4.3.2 Data-privacy & cybersecurity concerns
  • 4.3.3 Clinician cyber-sickness & ergonomic fatigue
  • 4.3.4 Fragmented device-certification pathways
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Bargaining Power of Suppliers
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts

• 5.1 By Component (Value, USD bn)
  • 5.1.1 Hardware
    • 5.1.1.1 Devices
      • 5.1.1.1.1 Head-Mounted Displays
      • 5.1.1.1.2 Gesture-Tracking Devices
      • 5.1.1.1.3 Projectors & Display Walls
      • 5.1.1.1.4 Other Devices
    • 5.1.1.2 Accessories
  • 5.1.2 Software
  • 5.1.3 Services
• 5.2 By Application (Value, USD bn)
  • 5.2.1 Surgery Simulation & Training
  • 5.2.2 Pain Management & PTSD
  • 5.2.3 Rehabilitation & Physical Therapy
  • 5.2.4 Medical Education & Training
  • 5.2.5 Patient Care Management
  • 5.2.6 Other Applications
• 5.3 By End-User (Value, USD bn)
  • 5.3.1 Hospitals & Clinics
  • 5.3.2 Academic & Research Institutes
  • 5.3.3 Rehabilitation Centers
  • 5.3.4 Diagnostic Centers
  • 5.3.5 Other End-Users
• 5.4 By Delivery Mode (Value, USD bn)
  • 5.4.1 Immersive VR
  • 5.4.2 Semi-Immersive VR
  • 5.4.3 Non-Immersive VR
• 5.5 By Geography (Value, USD bn)
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 South Korea
    • 5.5.3.5 Australia
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 South America
    • 5.5.4.1 Brazil
    • 5.5.4.2 Argentina
    • 5.5.4.3 Rest of South America
  • 5.5.5 Middle East and Africa
    • 5.5.5.1 GCC
    • 5.5.5.2 South Africa
    • 5.5.5.3 Rest of Middle East and Africa

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Microsoft Corporation
  • 6.3.2 Meta Platforms, Inc.
  • 6.3.3 HTC Corporation
  • 6.3.4 Sony Group Corporation
  • 6.3.5 Siemens Healthineers AG
  • 6.3.6 GE HealthCare Technologies Inc.
  • 6.3.7 Osso VR, Inc.
  • 6.3.8 Surgical Theater, Inc.
  • 6.3.9 MindMaze SA
  • 6.3.10 XRHealth USA, Inc.
  • 6.3.11 AppliedVR, Inc.
  • 6.3.12 Medical Realities Ltd.
  • 6.3.13 SyncThink, Inc.
  • 6.3.14 Vicarious Surgical, Inc.
  • 6.3.15 ImmersiveTouch, Inc.
  • 6.3.16 Samsung Electronics Co., Ltd.
  • 6.3.17 VirtaMed AG
  • 6.3.18 CAE Inc.
  • 6.3.19 FundamentalVR Ltd.
  • 6.3.20 BehaVR, LLC

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment